These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6484205)

  • 1. Therapeutic potential for blood-brain barrier modification in malignant brain tumor.
    Neuwelt EA
    Prog Exp Tumor Res; 1984; 28():51-66. PubMed ID: 6484205
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
    Neuwelt EA; Rapoport SI
    Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inability of dimethyl sulfoxide to increase brain uptake of water-soluble compounds: implications to chemotherapy for brain tumors.
    Greig NH; Sweeney DJ; Rapoport SI
    Cancer Treat Rep; 1985 Mar; 69(3):305-12. PubMed ID: 3978658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier.
    Neuwelt EA; Barnett P; Barranger J; McCormick C; Pagel M; Frenkel E
    Neurosurgery; 1983 Jan; 12(1):29-34. PubMed ID: 6219298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
    Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
    Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT monitoring of chemotherapeutic agent delivery after osmotic blood brain barrier disruption.
    Neuwelt EA
    Clin Neurosurg; 1981; 28():520-31. PubMed ID: 6895614
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy in brain tumors].
    van den Bent MJ; Schellens JH; Sillevis Smitt PA; Vecht CJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(13):702-6. PubMed ID: 8668248
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomas.
    Heimberger K; Samec P; Binder H; Podreka I; Reisner T; Deecke L; Horaczek A; Dittrich C; Steger G; Zimpfer M
    Acta Radiol Suppl; 1986; 369():223-6. PubMed ID: 2980457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ketoconazole penetration across the blood-brain barrier of mice by dimethyl sulfoxide.
    Iwen PC; Miller NG
    Antimicrob Agents Chemother; 1986 Oct; 30(4):617-8. PubMed ID: 3789696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of dimethyl sulfoxide to reversibly open the blood-brain barrier to protein.
    Salcman M; Broadwell R; Kaplan R; Egorin M
    Neurosurgery; 1983 Feb; 12(2):251. PubMed ID: 6835511
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma.
    Hill SA; Neuwelt EA
    J Neurosurg Nurs; 1982 Apr; 14(2):94-7. PubMed ID: 6811704
    [No Abstract]   [Full Text] [Related]  

  • 12. Dimethyl sulfoxide: breakdown of blood-brain barrier?
    Kocsis JJ; Harkaway S; Vogel WH
    Science; 1968 Jun; 160(3835):1472-3. PubMed ID: 4385205
    [No Abstract]   [Full Text] [Related]  

  • 13. Little effect of dimethyl sulfoxide on blood-brain barrier to dopamine.
    Walters A; Jackson-Lewis V; Fahn S
    Experientia; 1984 Aug; 40(8):859-61. PubMed ID: 6468603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid therapy in patients with cerebral tumors: benefits, mechanisms, problems, practicalities.
    Gutin PH
    Semin Oncol; 1975 Mar; 2(1):49-56. PubMed ID: 795033
    [No Abstract]   [Full Text] [Related]  

  • 15. Dimethyl sulfoxide: breakdown of blood-brain barrier?
    Brink JJ; Stein DG
    Science; 1968 Jun; 160(3835):1473. PubMed ID: 4385206
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
    Neuwelt EA; Diehl JT; Vu LH; Hill SA; Michael AJ; Frenkel EP
    Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic effect of dimethyl sulfoxide on the blood-brain barrier.
    Broadwell RD; Salcman M; Kaplan RS
    Science; 1982 Jul; 217(4555):164-6. PubMed ID: 7089551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification.
    Neuwelt EA; Pagel M; Barnett P; Glassberg M; Frenkel EP
    Cancer Res; 1981 Nov; 41(11 Pt 1):4466-70. PubMed ID: 6796261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.
    Neuwelt EA; Frenkel EP; Diehl J; Vu LH; Rapoport S; Hill S
    Neurosurgery; 1980 Jul; 7(1):44-52. PubMed ID: 6251399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.
    Neuwelt EA; Maravilla KR; Frenkel EP; Rapaport SI; Hill SA; Barnett PA
    J Clin Invest; 1979 Aug; 64(2):684-8. PubMed ID: 457877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.